Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Current Deferred Revenue (2019 - 2022)

Aethlon Medical (AEMD) has disclosed Current Deferred Revenue for 4 consecutive years, with $574245.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Current Deferred Revenue rose 150.0% year-over-year to $574245.0, compared with a TTM value of $574245.0 through Dec 2022, up 150.0%, and an annual FY2022 reading of $344547.0, up 200.0% over the prior year.
  • Current Deferred Revenue was $574245.0 for Q4 2022 at Aethlon Medical, roughly flat from $574245.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $574245.0 in Q3 2022 and bottomed at $100000.0 in Q3 2019.
  • Average Current Deferred Revenue over 4 years is $280033.0, with a median of $229698.0 recorded in 2021.
  • The sharpest move saw Current Deferred Revenue soared 407.02% in 2020, then tumbled 77.35% in 2021.
  • Year by year, Current Deferred Revenue stood at $100000.0 in 2019, then skyrocketed by 407.02% to $507022.0 in 2020, then tumbled by 54.7% to $229698.0 in 2021, then surged by 150.0% to $574245.0 in 2022.
  • Business Quant data shows Current Deferred Revenue for AEMD at $574245.0 in Q4 2022, $574245.0 in Q3 2022, and $459396.0 in Q2 2022.